View in EDS HTML Full Text PDF Full Text

Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma.

Saved in:
Bibliographic Details
Title: Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma.
Authors: Okamoto H; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Yoshimatsu Y; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Tomizawa T; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Kunita A; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Takayama R; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Morikawa T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Komura D; Department of Genomic Pathology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Takahashi K; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Oshima T; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Sato M; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Komai M; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Podyma-Inoue KA; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Uchida H; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Hamada H; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Fujiu K; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Department of Advanced Cardiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Ishikawa S; Department of Genomic Pathology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Fukayama M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Fukuhara T; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan., Watabe T; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. t-watabe@umin.ac.jp.; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. t-watabe@umin.ac.jp.
Source: Scientific reports [Sci Rep] 2019 Feb 04; Vol. 9 (1), pp. 1281. Date of Electronic Publication: 2019 Feb 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30718742
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Okamoto+H%22">Okamoto H</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimatsu+Y%22">Yoshimatsu Y</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tomizawa+T%22">Tomizawa T</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kunita+A%22">Kunita A</searchLink>; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takayama+R%22">Takayama R</searchLink>; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Morikawa+T%22">Morikawa T</searchLink>; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Komura+D%22">Komura D</searchLink>; Department of Genomic Pathology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+K%22">Takahashi K</searchLink>; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Oshima+T%22">Oshima T</searchLink>; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+M%22">Sato M</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Komai+M%22">Komai M</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Podyma-Inoue+KA%22">Podyma-Inoue KA</searchLink>; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Uchida+H%22">Uchida H</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Project Division of Cancer Biomolecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hamada+H%22">Hamada H</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Fujiu+K%22">Fujiu K</searchLink>; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Department of Advanced Cardiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ishikawa+S%22">Ishikawa S</searchLink>; Department of Genomic Pathology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Fukayama+M%22">Fukayama M</searchLink>; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuhara+T%22">Fukuhara T</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Watabe+T%22">Watabe T</searchLink>; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. t-watabe@umin.ac.jp.; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. t-watabe@umin.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2019 Feb 04; Vol. 9 (1), pp. 1281. <i>Date of Electronic Publication: </i>2019 Feb 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30718742
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-019-39018-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1281
    Titles:
      – TitleFull: Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Okamoto H
      – PersonEntity:
          Name:
            NameFull: Yoshimatsu Y
      – PersonEntity:
          Name:
            NameFull: Tomizawa T
      – PersonEntity:
          Name:
            NameFull: Kunita A
      – PersonEntity:
          Name:
            NameFull: Takayama R
      – PersonEntity:
          Name:
            NameFull: Morikawa T
      – PersonEntity:
          Name:
            NameFull: Komura D
      – PersonEntity:
          Name:
            NameFull: Takahashi K
      – PersonEntity:
          Name:
            NameFull: Oshima T
      – PersonEntity:
          Name:
            NameFull: Sato M
      – PersonEntity:
          Name:
            NameFull: Komai M
      – PersonEntity:
          Name:
            NameFull: Podyma-Inoue KA
      – PersonEntity:
          Name:
            NameFull: Uchida H
      – PersonEntity:
          Name:
            NameFull: Hamada H
      – PersonEntity:
          Name:
            NameFull: Fujiu K
      – PersonEntity:
          Name:
            NameFull: Ishikawa S
      – PersonEntity:
          Name:
            NameFull: Fukayama M
      – PersonEntity:
          Name:
            NameFull: Fukuhara T
      – PersonEntity:
          Name:
            NameFull: Watabe T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 02
              Text: 2019 Feb 04
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 2045-2322
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific reports
              Type: main
ResultId 1